New Edge Advisors, LLC Charles River Laboratories International, Inc. Transaction History

New Edge Advisors, LLC

$18.3 Billion
Q2 2025

A detailed history of New Edge Advisors, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 442 shares of CRL stock, worth $75,422. This represents 0.0% of its overall portfolio holdings.

Number of Shares

442

Previous 438 0.91%

Holding current value

$75,422

Previous $65,000 3.08%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$99.75 - $151.89 $399 - $607	4 Added 0.91%	442 $67,000
Q1 2025 May 15, 2025	SELL	$150.52 - $190.14 $12,944 - $16,352	-86 Reduced 16.41%	438 $65,000
Q4 2024 Feb 13, 2025	SELL	$178.58 - $220.69 $21,786 - $26,924	-122 Reduced 18.89%	524 $96,000
Q3 2024 Nov 14, 2024	SELL	$187.96 - $245.29 $313,517 - $409,143	-1,668 Reduced 72.08%	646 $127,000
Q2 2024 Aug 15, 2024	SELL	$206.39 - $268.73 $211,549 - $275,448	-1,025 Reduced 30.7%	2,314 $478,000
Q1 2024 May 14, 2024	BUY	$203.52 - $273.43 $165,258 - $222,025	812 Added 32.13%	3,339 $904,000
Q4 2023 Feb 13, 2024	BUY	$164.52 - $238.84 $77,159 - $112,015	469 Added 22.79%	2,527 $597,000
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $40,054 - $44,827	206 Added 11.12%	2,058 $403,000
Q2 2023 Aug 14, 2023	BUY	$183.71 - $210.25 $16,901 - $19,343	92 Added 5.23%	1,852 $389,000
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $90,955 - $123,202	474 Added 36.86%	1,760 $355,000
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $253,483 - $321,590	1,286 New	1,286 $280,000
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $682,211 - $966,833	-2,670 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$351.38 - $448.68 $574,154 - $733,143	-1,634 Reduced 37.96%	2,670 $1.01 Million
Q3 2021 Oct 29, 2021	BUY	$372.64 - $458.3 $292,895 - $360,223	786 Added 22.34%	4,304 $1.78 Million
Q2 2021 Jul 22, 2021	BUY	$294.17 - $371.65 $1.03 Million - $1.31 Million	3,518 New	3,518 $1.3 Million
Q3 2017 Nov 13, 2017	SELL	$96.72 - $109.26 $2,127 - $2,403	-22 Closed	0 $0
Q2 2017 Aug 16, 2017	BUY	N/A	22	22 $0

Others Institutions Holding CRL

# of Institutions

616

Shares Held

52.7M

Call Options Held

1.42M

Put Options Held

1.42M

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.68B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Edge Advisors, LLC with notifications on news.

Account

New Edge Advisors, LLC Charles River Laboratories International, Inc. Transaction History